Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia

Blood Cells, Molecules, and Diseases

Volumn 47, Issue 1, 2011, Pages 23-28

  Silva, Danilo Grünig Humberto ^a   Belini Junior, Edis ^a   Torres, Lidiane de Souza ^a   Ricci Júnior, Octávio ^b   Lobo, Clarisse de Castro ^c   Bonini Domingos, Claudia Regina ^a   De Almeida, Eduardo Alves ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Base Hospital of São José do Rio Preto FUNFARME   (Brazil)

^c Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti   (Brazil)

Author keywords

GST polymorphisms; Hydroxyurea; Oxidative stress; Sickle cell anemia

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN; HYDROXYUREA; TROLOX C;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HEMOGLOBINS; HUMANS; HYDROXYUREA; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 79956321998     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2011.03.004     Document Type: Article

References (66)

1. Taylor J.G., Ackah D., Cobb C., et al. Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Am. J. Hematol. 2008, 83:6-14.
2. Embury S.H., Mohandas N., Paszty C., et al. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J. Clin. Invest. 1999, 103:915-920.
3. Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl Acad. Sci. U.S A. 1988, 85:237-241.
4. Kato G.J., Gladwin M.T. Mechanisms and clinical complications of hemolysis in sickle cell disease and thalassemia. Disorders of Hemoglobin 2009, 201-224. Cambridge University Press, Cambridge. M.H. Steinberg, B.G. Forget, D.R. Higgs, D.J. Weatherall (Eds.).
5. Dasgupta T., Hebbel R.P., Kaul D.K. Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radic. Biol. Med. 2006, 41:1771-1780.
6. Conran N., Franco-Penteado C.F., Costa F.F. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 2009, 33:1-16.
7. Cho C.S., Kato G.J., Yang S.H., et al. Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxid. Redox Signal. 2010, 13:1-11.
8. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166.
9. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45:51-88.
10. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30:445-600.
11. Rushmore T.H., Pickett C.B. Glutathione S-transferases, structure, regulation, and therapeutic implications. J. Biol. Chem. 1993, 268:11475-11478.
12. Rinaldi R., Eliasson E., Swedmark S., Morgenstern R. Reactive intermediates and the dynamics of glutathione transferases. Drug Metab. Dispos. 2002, 30:1053-1058.
13. Sharma V., Kumar B., Saxena R. Glutathione S-transferase gene deletions and their effect on iron status in HbE/beta thalassemia patients. Ann. Hematol. 2010, 89:411-414.
14. Ware R.E., Aygun B. Advances in the use of hydroxyurea. Hematology Am. Soc. Hematol. Educ. Program. 2009, 62-69.
15. Aliyu Z.Y., Tumblin A.R., Kato G.J. Current therapy of sickle cell disease. Haematologica 2006, 91:7-11.
16. Lanaro C., Franco-Penteado C.F., Albuqueque D.M., et al. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J. Leukoc. Biol. 2009, 85:235-242.
17. Bonini-Domingos C.R. Metodologias Laboratoriais Para o Diagnóstico de Hemoglobinopatias e Talassemias 2006, NH, São José do Rio Preto.
18. Saiki R.K., Scharf S., Faloona F., et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle-cell anemia. Science 1985, 230:1350-1354.
19. AbdelRahman S.Z., Elzein R.A., Anwar W.A., Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 1996, 107:229-233.
20. Nock N.L., Bock C., Neslund-Dudas C., et al. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 2009, 20:1915-1926.
21. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
22. Re R., Pellegrini N., Proteggente A., et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26:1231-1237.
23. Keen J.H., Habig W.H., Jakoby W.B. Mechanism for several activities of glutathione S-transferases. J. Biol. Chem. 1976, 251:6183-6188.
24. Beutler E. Red cell metabolism. A manual of biochemical methods. Ann. Intern. Med. 1975, 83:919.
25. Rodriguez-Ariza A., Toribio F., Lopezbarea J. Rapid-determination of glutathione status in fish liver using high-performance liquid-chromatography and electrochemical detection. J. Chromatogr. B Biomed. Appl. 1994, 656:311-318.
26. Thein S.L., Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br. J. Haematol. 2009, 145:455-467.
27. Van Delft P., Lenters E., Bakker-Verweij M., et al. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int. J. Lab. Hematol. 2009, 31:484-495.
28. Kwiatkowski J.L., Yim E., Miller S., Adams R.J. Effect of transfusion therapy on transcranial doppler ultrasonography velocities in children with sickle cell disease. Pediatr. Blood Cancer 2010 Dec 23, -ediatr.
29. Thein S.L. Genetic modifiers of the â-haemoglobinopathies. Br. J. Haematol. 2008, 141:357-366.
30. Vekilov P.G. Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?. Br. J. Haematol. 2007, 139:173-184.
31. Fertrin K.Y., Costa F.F. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Rev. Hematol. 2010, 3:443-458.
32. Rossini A., Rapozo D.C., Amorim L.M., et al. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet. Mol. Res. 2002, 1:233-240.
33. Mo Z., Gao Y., Cao Y., et al. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009, 69:662-688.
34. Lima M.M., Oliveira M.N., Granja F., et al. Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients. Folia Biol. (Praha) 2008, 54:102-108.
35. Pinhel M.A.S., Nakazone M.A., Cacao J.C., et al. Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. Lab. Med. 2008, 46:439-445.
36. L.S. Ondei. Estresse oxidativo em pacientes beta talassêmicos e com deficiência de glicose-6-fosfato desidrogenase. 2009. Sao Jose do Rio Preto: Instituto de Biociências, Letras e Ciências Exatas, Universidade Estadual Paulista. Ref Type: Thesis/Dissertation.
37. Magno L.A.V., Talbot J., Talbot T., et al. Glutathione S-transferase variants in a Brazilian population. Pharmacology 2009, 83:231-236.
38. Tamer L., Calikoglu M., Ates N.A., et al. Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 2004, 9:493-498.
39. Zhong S.L., Zhou S.F., Chen X., et al. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur. J. Pharm. Sci. 2006, 28:77-85.
40. Kilburn L., Okcu M.F., Wang T., et al. Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer 2010, 116:2242-2249.
41. Bessa S.S., Ali E.M.M., Hamdy S.M. The role of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur. J. Intern. Med. 2009, 20:625-630.
42. Manfredini V., Lazzaretti L.L., Griebeler I.H., et al. Blood antioxidant parameters in sickle cell anemia patients in steady state. J. Natl Med. Assoc. 2008, 100:897-902.
43. Alsultan A.I., Seif M.A., Amin T.T., et al. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease. Eur. Rev. Med. Pharmacol. Sci. 2010, 14:527-538.
44. Repka T., Hebbel R.P. Hydroxyl radical formation by sickle erythrocyte-membranes-role of pathological iron deposits and cytoplasmic reducing agents. Blood 1991, 78:2753-2758.
45. Sess E.D., Carbonneau M.A., Meite M., et al. Markers of lipid peroxidation, inflammatory proteins and plasma tocopherols in homozygotic and heterozygotic sickle cell anemia. Bull. Soc. Pathol. Exot. 1998, 91:238-241.
46. Agil A., Sadrzadeh S.M.H. Hydroxy-urea protects erythrocytes against oxidative damage. Redox Rep. 2000, 5:29-34.
47. Shimauti E.L., Silva D.G., de Almeida E.A., et al. Serum melatonin level and oxidative stress in sickle cell anemia. Blood Cells Mol. Dis. 2010, 45:297-301.
48. Maher P. Redox control of neural function: background, mechanisms, and significance. Antioxid. Redox Signal. 2006, 8:1941-1970.
49. Nam D.T., Arseneault M., Murthy V., Ramassamy C. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr. Mol. Pharmacol. 2010, 3:66-78.
50. R.N. Hardwick, C.D. Fisher, M.J. Canet et al. Diversity in antioxidant response enzymes in progressive stages of human non-alcoholic fatty liver disease. Drug Metab Dispos. In press. 30-8-2010.Ref Type: In Press.
51. Burlakova E.B., Zhizhina G.P., Gurevich S.M., et al. Biomarkers of oxidative stress and smoking in cancer patients. J. Cancer Res. Ther. 2010, 6:47-53.
52. Johnson R.M., Goyette G., Ravindranath Y., Ho Y.S. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic. Biol. Med. 2005, 39:1407-1417.
53. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38:1543-1552.
54. Low F.M., Hampton M.B., Peskin A.V., Winterbourn C.C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 2007, 109:2611-2617.
55. Dasgupta T., Fabry M.E., Kaul D.K. Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R394-R402.
56. Venkatesha V.A., Venkataraman S., Sarsour E.H., et al. Catalase ameliorates polychlorinated biphenyl-induced cytotoxicity in nonmalignant human breast epithelial cells. Free Radic. Biol. Med. 2008, 45:1094-1102.
57. Liu R.M., Pravia K.A.G. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic. Biol. Med. 2010, 48:1-15.
58. Tatum V.L., Chow C.K. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radic. Res. 1996, 25:133-139.
59. Chaves M.A.F., Leonart M.S.S., do Nascimento A.J. Oxidative process in erythrocytes of individuals with hemoglobin S. Hematology 2008, 13:187-192.
60. Somjee S.S., Warrier R.P., Thomson J.L., et al. Advanced glycation end-products in sickle cell anaemia. Br. J. Haematol. 2005, 128:112-118.
61. Mansoor M.A., Svardal A.M., Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 1992, 200:218-229.
62. Dass P.D., Bermes E.W., Holmes E.W. Renal and hepatic output of glutathione in plasma and whole blood. Biochim. Biophys. Acta 1992, 1156:99-102.
63. Rossi R., Milzani A., le-Donne I., et al. Different metabolizing ability of thiol reactants in human and rat blood-biochemical and pharmacological implications. J. Biol. Chem. 2001, 276:7004-7010.
64. Thom S.R., Kang M., Fisher D., Ischiropoulos H. Release of glutathione from erythrocytes and other markers of oxidative stress in carbon monoxide poisoning. J. Appl. Physiol. 1997, 82:1424-1432.
65. Giustarini D., Milzani A., le-Donne I., Rossi R. Red blood cells as a physiological source of glutathione for extracellular fluids. Blood Cells Mol. Dis. 2008, 40:174-179.
66. Dumaswala U.J., Zhuo L., Mahajan S., et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am. J. Physiol. Cell Physiol. 2001, 280:C867-C873.